Rho-Kinase Inhibitor

DRUG2 trials

Sponsors

New York Glaucoma Research Institute

Conditions

Advanced GlaucomaChronic Angle-closure Glaucoma

Phase 2

A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Chronic Angle-closure Glaucoma

New York Glaucoma Research InstituteChronic Angle-closure Glaucoma

Start: 2014-05-31Target: 10Updated: 2015-04-24

A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt

New York Glaucoma Research InstituteAdvanced Glaucoma

Start: 2014-06-30Target: 10Updated: 2015-04-24